Predictive Oncology Inc (NASDAQ:POAI) has a beta value of 1.18 and has seen 54.49 million shares traded in the last trading session. The company, currently valued at $16.43M, closed the last trade at $1.89 per share which meant it gained $0.69 on the day or 57.50% during that session. The POAI stock price is -98.94% off its 52-week high price of $3.76 and 70.9% above the 52-week low of $0.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.56 million shares traded. The 3-month trading volume is 177.68K shares.
The consensus among analysts is that Predictive Oncology Inc (POAI) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Predictive Oncology Inc (NASDAQ:POAI) trade information
Sporting 57.50% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the POAI stock price touched $1.89 or saw a rise of 38.24%. Year-to-date, Predictive Oncology Inc shares have moved 130.49%, while the 5-day performance has seen it change 90.91%. Over the past 30 days, the shares of Predictive Oncology Inc (NASDAQ:POAI) have changed 154.73%. Short interest in the company has seen 0.15 million shares shorted with days to cover at 1.26.
Predictive Oncology Inc (POAI) estimates and forecasts
Figures show that Predictive Oncology Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 81.73% over the past 6 months, with this year growth rate of 40.23%, compared to 24.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 53.33% over the past 5 years.
POAI Dividends
Predictive Oncology Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Predictive Oncology Inc (NASDAQ:POAI)’s Major holders
Insiders own 2.16% of the company shares, while shares held by institutions stand at 4.01% with a share float percentage of 4.10%. Investors are also buoyed by the number of investors in a company, with Predictive Oncology Inc having a total of 17.0 institutions that hold shares in the company. The top two institutional holders are ADVISORNET FINANCIAL, INC with over 95.0 shares worth more than $99.0. As of 2024-06-30, ADVISORNET FINANCIAL, INC held 0.0023% of shares outstanding.
The other major institutional holder is CORNERSTONE PLANNING GROUP LLC, with the holding of over 1.0 shares as of 2024-06-30.
